SALLY SIRMANS: Open Payments
NPI 1447853601 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 53 payments from 14 companies in 2025. Trend: 2023 $330 · 2024 $1,018 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 7 | $171 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| E.R. Squibb & Sons, L.L.C. | 9 | $136 |
| Vanda Pharmaceuticals Inc. | 5 | $121 |
| ABBVIE INC. | 4 | $102 |
| Alkermes, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Almatica Pharma LLC | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
Products named: REXULTI, COBENFY, FANAPT, VRAYLAR, CAPLYTA, LOREEV XR, INGREZZA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
